Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 16,439
+360 (2.24%)
At close: Dec 15, 2025
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 210.69 billion as of December 15, 2025. Its market cap has increased by 9.90% in one year.
Market Cap
210.69B
Enterprise Value
211.65B
Revenue
15.33B
Ranking
n/a
PE Ratio
87.73
Stock Price
16,439.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 210.69B, an increase of 62,766.69%. That is a compound annual growth rate of 29.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 206.26B | 17.11% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | 14.04B | 161.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.31T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 883.90B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |